机器学习评估肺癌新辅助治疗后病理缓解:IASLC MPR项目
本研究利用病理学家手动标注的15,564个区域训练卷积神经网络模型和凸包算法,量化瘤床面积和残余存活肿瘤,并与IASLC可重复性研究中病理学家的评估结果比较。结果显示数字AI与病理学家平均病理缓解率高度相关(0.97),MPR一致性的κ值为0.82,且数字AI与病理学家在无复发生存和总生存上表现相似。
要点
- 数字AI与病理学家评估的MPR一致性κ为0.82,鳞癌高于非鳞癌。
- 数字AI与凸包算法在MPR上完全一致,与病理学家平均缓解率高度相关。
- 数字AI与病理学家评估的无复发生存和总生存相似。
核心结论
- 机器学习方法在NSCLC新辅助治疗后病理缓解评估中与病理学家高度一致,支持其应用价值。
研究设计与样本
- 使用15,564个病理学家手动标注区域训练卷积神经网络模型和凸包算法,并与IASLC可重复性研究中的病理学家评估比较。
主要发现
- 病理学家平均病理缓解率与数字AI相关系数为0.97,与凸包算法为0.97,数字AI与凸包算法为0.99。
- 数字AI与凸包算法在MPR上100%一致。
- 病理学家平均缓解率与数字AI/凸包算法MPR一致性的κ为0.82(95%CI:0.69,0.96),有6例不一致。
- 鳞癌一致性κ为0.92(95%CI:0.76,1.0),非鳞癌为0.77(95%CI:0.59,0.96)。
- 病理学家平均缓解率与数字AI显示相似的无复发生存和总生存。
临床怎么用
- 机器学习模型可用于量化瘤床和残余存活肿瘤,辅助病理缓解评估。
- 在鳞癌中一致性更高,非鳞癌需注意判读差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Machine learning algorithms may improve the efficiency and accuracy of pathologic response (PR) assessment in surgically resected lung cancers after neoadjuvant therapy. The aim of this study was to develop digital models for quantifying tumor bed (TB) area and residual viable tumor (VT) and to compare these results to previously published assessments of PR by pathologists from the International Association for the Study of Lung Cancer reproducibility study. METHODS: Manual pathologist annotations (N = 15,564) of regions including TB and VT were used to train a convolutional neural network model (digital artificial intelligence [AI]) and a convex hull algorithm (CHA). PR was determined by the percentage of VT in the TB area. The pathologists determined the average PR (APR) across slides (unweighted), which was compared with the weighted average for digital AI and CHA. The concordance between pathologist APR, digital AI, and CHA was calculated and correlated with outcomes. RESULTS: There was a strong correlation between approaches: APR versus digital AI (0.97), APR versus CHA (0.97), and digital AI versus CHA (0.99). Digital AI and CHA demonstrated 100% agreement for MPR. The κ concordance for MPR was 0.82 (95% confidence interval [CI]: 0.69, 0.96) for APR versus digital AI/CHA with six discordant cases. The concordance was higher for squamous cell carcinoma (κ = 0.92, 95% CI: 0.76, 1.0) than for nonsquamous carcinoma (κ = 0.77, 95% CI: 0.59, 0.96). APR and digital AI demonstrated similar relapse-free survival and overall survival. CONCLUSION: The overall high level of agreement supports the utility of machine learning approaches for evaluation of PR in patients with NSCLC.
引用
- Dacic S, Shenker D, Redman M, et al. Machine Learning Assessment of Pathologic Response in Lung Cancer Resections After Neoadjuvant Therapy-IASLC MPR Project. J Thorac Oncol. 2026. PMID: 42229633. doi:10.1016/j.jtho.2026.103953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。